Workflow
Mingyue Optical Lens(301101)
icon
Search documents
明月镜片:关于召开公司2023年第二次临时股东大会的通知
2023-10-23 10:08
证券代码:301101 证券简称:明月镜片 公告编号:2023-036 明月镜片股份有限公司 关于召开公司 2023 年第二次临时股东大会的通知 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 明月镜片股份有限公司(以下简称"公司")于 2023 年 10 月 23 日召开的第 二届董事会第七次会议审议通过了《关于召开公司 2023 年第二次临时股东大会 的议案》,决定于 2023 年 11 月 8 日(星期三)14:30 召开 2023 年第二次临时股 东大会,现将有关事项通知如下: 一、会议召开的基本情况 (一)会议届次:2023 年第二次临时股东大会 (二)会议召集人:董事会。公司第二届董事会第七次会议于 2023 年 10 月 23 日召开,审议通过了《关于召开公司 2023 年第二次临时股东大会的议案》, 同意召开本次股东大会。 (三)会议召开的合法性及合规性:本次董事会召开股东大会会议符合有关 法律、行政法规、部门规章、规范性文件和《公司章程》的相关规定。 (四)会议召开日期、时间: 1、会议召开时间:2023 年 11 月 8 日(星期三)14: ...
明月镜片:第二届董事会第七次会议决议公告
2023-10-23 10:02
证券代码:301101 证券简称:明月镜片 公告编号:2023-032 明月镜片股份有限公司 第二届董事会第七次会议决议公告 二、董事会会议审议情况 经与会董事充分讨论,本次会议审议通过议案如下: (一)审议通过《关于<2023 年第三季度报告>的议案》; 表决结果:7 票同意;0 票反对;0 票弃权。 具体内容详见同日披露于巨潮资讯网(www.cninfo.com.cn)上的《2023 年第 三季度报告》。 (二)审议通过《关于聘任公司 2023 年年度会计师事务所的议案》; 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 明月镜片股份有限公司(以下简称"公司")第二届董事会第七次会议于 2023 年 10 月 23 日在公司会议室以现场结合通讯的表决方式召开。本次会议通知于 2023 年 10 月 11 日以专人送达、电话、微信的方式通知了全体董事。本次会议由董事长 谢公晚先生主持,应出席会议董事 7 人,实际参加会议董事 7 人,公司监事、高级 管理人员列席会议。会议召开符合《中华人民共和国公司法》、《公司章程》等规定, 会议合法 ...
明月镜片:关于聘任公司2023年年度会计师事务所的公告
2023-10-23 10:02
证券代码:301101 证券简称:明月镜片 公告编号:2023-035 截至 2022 年末,立信拥有合伙人 267 名、注册会计师 2,392 名、从业人员 总数 10,620 名,签署过证券服务业务审计报告的注册会计师人数 674 名。 立信 2022 年业务收入(经审计)46.14 亿元,其中审计业务收入 34.08 亿 元,证券业务收入 15.16 亿元。 2022 年度立信为 646 家上市公司提供年报审计服务,审计收费 8.17 亿元, 同行业上市公司审计客户 24 家。 明月镜片股份有限公司 关于聘任公司 2023 年年度会计师事务所的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有虚 假记载、误导性陈述或重大遗漏。 明月镜片股份有限公司(以下简称"公司")于 2023 年 10 月 23 日召开了第 二届董事会第七次会议,审议通过了《关于聘任公司 2023 年年度会计师事务所 的议案》,董事会同意继续聘请立信会计师事务所(特殊普通合伙)(以下简称"立 信")为公司 2023 年度审计机构。本议案尚需提交公司 2023 年第二次临时股东 大会审议,自股东大会审议通过之日起生效 ...
明月镜片(301101) - 明月镜片调研活动信息
2023-08-15 01:36
明月镜片股份有限公司 投资者关系活动记录表 | --- | --- | --- | |------------|-----------------------|------------------------------------------------------------------------------------------------------------------------------| | 投资者关系 | √特定对象调研 | | | 活动类别 | □媒体采访 □业绩说明会 | | | | □新闻发布会 | | | | □现场参观 | | | | □其他 | | | 参与单位 | 中金公司、 | Allianz Global Investors Luxembourg S.A、Alpines | | | | 、FIL HKCHAPLT、Goldman Sachs Asset Management International、JM GREAT | | | | CHINA FUND、Matthews International Capital Management,LLC、 | | | | ...
明月镜片(301101) - 2023 Q2 - 季度财报
2023-08-07 16:00
Financial Performance - The company's operating revenue for the first half of 2023 was ¥365,939,936.15, representing a 27.78% increase compared to ¥286,390,640.49 in the same period last year[22]. - The net profit attributable to shareholders of the listed company was ¥80,121,334.97, up 53.38% from ¥52,236,561.21 in the previous year[22]. - The net profit attributable to shareholders after deducting non-recurring gains and losses was ¥70,481,826.51, an increase of 81.56% compared to ¥38,819,244.58 in the same period last year[22]. - The net cash flow from operating activities was ¥94,584,559.32, reflecting a 55.17% increase from ¥60,956,040.83 in the previous year[22]. - Basic earnings per share rose to ¥0.3976, a 53.40% increase from ¥0.2592 in the same period last year[22]. - The company's total profit for the first half of 2023 was CNY 100.06 million, a 47.2% increase from CNY 67.97 million in the same period last year[178]. - The total comprehensive income for the first half of 2023 was 80.1 million, representing a 6.79% increase compared to the previous period[186]. - The company reported a significant increase in retained earnings, with a balance of 201,510,000 at the end of the period[193]. Assets and Liabilities - Total assets at the end of the reporting period were ¥1,702,413,138.81, a 2.58% increase from ¥1,659,522,369.65 at the end of the previous year[22]. - The total liabilities increased slightly to ¥148,625,002.62 from ¥147,620,954.99, showing a marginal rise of 0.7%[168]. - Cash and cash equivalents decreased significantly from ¥915,192,342.31 at the beginning of the year to ¥476,725,029.31, a decline of 47.9%[170]. - The total liabilities at the end of the reporting period were 550,230,000, showing effective management of financial obligations[193]. Research and Development - Research and development expenses rose by 26.92% to ¥11.26 million, compared to ¥8.87 million in the same period last year[61]. - The R&D expenditure for the first half of 2023 was 28.7 million, accounting for 5.11% of total revenue[186]. - The company has established partnerships with top research institutions to drive technological advancements, focusing on myopia prevention and functional optical lenses[48]. - As of June 30, 2023, the company holds 161 patents, including 25 invention patents, demonstrating its commitment to innovation and technology[49]. Market Strategy and Expansion - The company aims to become the leading brand in the Chinese lens market, focusing on brand promotion and channel expansion[35]. - The company plans to expand its presence in the medical channel, having completed the establishment of a dedicated team in 2022[35]. - The company is actively expanding its online presence with flagship stores on platforms like Tmall and JD, integrating online and offline sales channels[56]. - The company plans to enhance its mid-to-high-end product line capacity through fundraising projects, although there are risks of not achieving expected returns[89]. - The company plans to expand its market presence and invest in new product development, aiming for a 20% increase in market share by the end of 2024[186]. Environmental Responsibility - The company invested a total of ¥1,223,080.76 in environmental governance and protection during the reporting period[107]. - The company emphasizes a "high efficiency, low energy consumption" green production model to support national carbon reduction goals[108]. - The company has implemented a self-monitoring plan for pollutants, with results showing no exceedances of standards[103]. - The company has committed to reducing carbon emissions through energy management and resource conservation initiatives[108]. Shareholder and Dividend Information - The company plans to increase its dividend payout ratio to 20% in the upcoming fiscal year, enhancing shareholder returns[186]. - The company distributed cash dividends of RMB 3.00 per 10 shares and issued 5 bonus shares, totaling cash dividends of RMB 40,302,420 on May 23, 2023[110]. - The company has implemented a profit distribution policy to enhance shareholder returns and maintain good communication with investors[110]. Corporate Governance - The company has a robust internal control system to protect shareholder rights and ensure accurate information disclosure[109]. - The company has not experienced any significant litigation or arbitration matters during the reporting period[122]. - The company has not engaged in any asset or equity acquisition or sale transactions during the reporting period[125]. Product Development - The company launched the "Easy Control" series of myopia management lenses, which received professional recognition and increased sales confidence among customers[112]. - The company has launched a total of 18 SKUs in the myopia management lens category, maintaining a significant lead in product line richness[51]. - The "Light Control" series products amounted to CNY 54.81 million, showing a significant year-on-year growth of 76%[36]. Customer Engagement - As of June 30, 2023, the company had 2,504 direct sales customers and 46 distribution customers, with direct sales channel revenue of 224.68 million yuan, accounting for 61.40% of total revenue[43]. - The company has established a stable channel structure with tens of thousands of offline terminal stores, enhancing customer engagement through product tasting events and customer salons[54].
明月镜片:明月镜片业绩说明会、路演活动等
2023-05-26 09:14
明月镜片股份有限公司 投资者关系活动记录表 编号:2023-002 | | ☐特定对象调研 ☐分析师会议 | | --- | --- | | | ☐媒体采访 业绩说明会 | | 投资者关系活动类别 | ☐新闻发布会 ☐路演活动 | | | ☐现场参观 | | | ☐其他(请文字说明其他活动内容) | | 参与单位 | 投资者网上提问 | | 时间 | 2023年5月25日 | | 地点 | 价值在线(https://www.ir-online.cn/)网络互动 | | | 董事长谢公晚 | | 上市公司接待人员姓名 | 董事会秘书兼副总经理曾哲 | | | 独立董事张银杰 | | | 财务总监尉静妮 | | | 1 .公司未来对智能眼镜有没有规划? | | | 答:公司目前在小米有品旗舰店售卖的智能眼镜sasky具有语音 | | | 助手功能,可以语音唤醒SIRI、小艺、小爱同学,并具有接打电 | | | 话、导航等功能。公司在立足主营业务的同时积极关注布局眼视光 | | | 行业前瞻性技术。 | | | 2 .请问公司是否有在多家医院做轻松控防控效果临床的计划? | | | 感谢! | | | 答:202 ...
明月镜片:关于举行2022年度网上业绩说明会的公告
2023-05-22 07:46
证券代码:301101 证券简称:明月镜片 公告编号:2023-024 明月镜片股份有限公司 关于举办 2022 年度网上业绩说明会的公告 会议召开方式:网络互动方式 二、参加人员 董事长谢公晚先生、董事会秘书兼副总经理曾哲先生、独立董事张银杰女 士、财务总监尉静妮女士。 会议召开地点:价值在线(www.ir-online.cn) 一、说明会召开的时间、地点和方式 会议召开时间:2023 年 5 月 25 日(星期四)15:00-17:00 会议召开时间:2023 年 5 月 25 日(星期四)15:00-17:00 会议召开方式:网络互动方式 会议召开地点:价值在线(www.ir-online.cn) 会 议 问 题 征 集 : 投 资 者 可 于 2023 年 5 月 25 日 前 访 问 网 址 https://eseb.cn/14JeIetaQyQ 或使用微信扫描下方小程序码进行会前 提问,公司将通过本次业绩说明会,在信息披露允许范围内就投资者普 遍关注的问题进行回答。 本公司及董事会全体成员保证信息披露内容的真实、准确和完整,没有 虚假记载、误导性陈述或重大遗漏。 重要内容提示: 明月镜片股份有限公 ...
明月镜片(301101) - 2023 Q1 - 季度财报
2023-04-23 16:00
Financial Performance - The company's operating revenue for Q1 2023 was ¥171,613,712, representing a 26% increase compared to ¥136,199,535.62 in the same period last year[4] - Net profit attributable to shareholders for Q1 2023 was ¥35,050,749.84, a 58.5% increase from ¥22,113,773.37 year-on-year[4] - Basic earnings per share for Q1 2023 were ¥0.2609, reflecting a 58.51% increase compared to ¥0.1646 in the same period last year[4] - Operating profit for the quarter was ¥43,335,541.06, representing a growth of 50.5% from ¥28,804,339.42 in Q1 2022[24] - The total comprehensive income for the period was ¥37,909,230.85, compared to ¥24,309,914.27 in the same quarter last year[24] Cash Flow and Assets - The net cash flow from operating activities reached ¥31,429,846.37, up 234.81% from ¥9,387,448.32 in the previous year[4] - The cash and cash equivalents decreased by 50.20% to ¥465,092,522.18, primarily due to investments in financial products[10] - The net cash flow from investing activities was negative at ¥498,963,185.24, a 37.49% improvement compared to the previous year, reflecting reduced investment in structured deposits[13] - The net cash flow from financing activities was -1,232,325.04 CNY, resulting in a total cash outflow of 16,684,386.56 CNY[27] - The ending balance of cash and cash equivalents was 465,092,522.18 CNY, down from 934,006,089.92 CNY at the beginning of the period[27] Assets and Liabilities - Total assets at the end of Q1 2023 amounted to ¥1,699,705,694.73, a 2.42% increase from ¥1,659,522,369.65 at the end of the previous year[4] - The total current liabilities increased slightly to CNY 140.04 million from CNY 136.23 million at the beginning of the year[21] - The company's non-current liabilities decreased to CNY 9.85 million from CNY 11.39 million at the beginning of the year[21] - The total equity remained stable at CNY 1,036.83 million[21] Sales and Market Performance - In Q1 2023, the sales of the "Easy Control" series products reached CNY 27.57 million, representing a year-on-year growth of 80%[18] - The company reported a strong recovery in offline consumption starting from February 2023, indicating a positive market outlook[18] - The company is focusing on expanding its market presence and enhancing product offerings in response to growing demand[18] Expenses and Investments - The company reported a significant increase in sales expenses, which rose by 32.88% to ¥33,076,283.58, due to higher advertising expenditures[12] - Research and development expenses rose to ¥5,325,996.18, up from ¥4,135,120.23 in the previous year, indicating a focus on innovation[23] Other Financial Metrics - The company's weighted average return on equity was 2.36%, up from 1.56% in the same period last year, indicating improved profitability[4] - Trade receivables increased by 30.95% to ¥148,259,308.49, attributed to higher sales and increased accounts receivable[10] - The inventory decreased to CNY 81.07 million from CNY 89.73 million at the beginning of the year[20] - The accounts receivable rose to CNY 148.26 million from CNY 113.22 million at the beginning of the year[20] - The company did not undergo an audit for the first quarter report[28]
明月镜片(301101) - 2022 Q4 - 年度财报
2023-04-18 16:00
Financial Performance - The company's operating revenue for 2022 was ¥623,065,041.29, representing an increase of 8.25% compared to ¥575,569,283.16 in 2021[18]. - Net profit attributable to shareholders for 2022 was ¥136,185,210.67, a significant increase of 65.89% from ¥82,094,094.80 in 2021[18]. - The basic earnings per share for 2022 was ¥1.0137, up 24.41% from ¥0.8148 in 2021[18]. - The total assets at the end of 2022 amounted to ¥1,659,522,369.65, reflecting a growth of 4.02% from ¥1,595,387,682.94 at the end of 2021[18]. - The company's total revenue for 2022 was CNY 623.07 million, an increase of 8.25% compared to the previous year[53]. - Revenue from lens business reached CNY 477.80 million, up 5.63% year-on-year, while raw material revenue surged by 44.93% to CNY 89.15 million[55]. - The company's gross profit margin for lens products was 60.04%, reflecting a year-on-year increase of 2.97%[56]. - The company reported a net profit margin of 18% for 2022, reflecting improved operational efficiency and cost management[182]. Dividend and Capital Management - The company plans to distribute a cash dividend of 3.00 RMB per 10 shares to all shareholders based on a total share capital of 134,341,400 shares as of December 31, 2022[4]. - The company will increase its capital reserve by converting 5 shares for every 10 shares held by shareholders[4]. - The company distributed a cash dividend of 5.30 RMB per 10 shares, totaling 71,200,942 RMB (including tax) to shareholders based on a total share capital of 134,341,400 shares[152]. - The company plans to distribute a cash dividend of RMB 3.00 per 10 shares, totaling RMB 40,302,420, which represents 100% of the profit distribution amount[153]. - The total share capital after the capital reserve conversion will increase to 201,512,100 shares, with 67,170,700 shares being converted from capital reserves[153]. Research and Development - The company has a total of 152 patents as of December 31, 2022, including 21 invention patents, 110 utility model patents, and 21 design patents[46]. - The company has invested in brand building, enhancing its market influence through advertising and partnerships with popular media programs[42]. - The company will increase R&D investment and collaborate with renowned universities to enhance its technological capabilities, including establishing research centers with Shanghai University of Technology and Nanjing University of Technology[99]. - Research and development expenses increased by 25.21% to ¥22,369,466.61, reflecting the company's increased investment in R&D[64]. - Investment in R&D has increased by 15%, focusing on innovative technologies to maintain competitive advantage[184]. Market Position and Strategy - The company maintained a market share of 10.7% in the Chinese lens market, ranking first according to Euromonitor data[27]. - The company aims to become the leading brand in the Chinese lens market, withdrawing from price wars and focusing on brand development and channel expansion[34]. - The company plans to enhance the promotion of its "Easy Control" series products and expand its market presence in 2023[96]. - The company aims to increase its operational bases from one to four, expanding into Guangdong, Zhejiang, and Anhui provinces in addition to Jiangsu[97]. - The company is exploring potential mergers and acquisitions to strengthen its competitive position, with a budget of 500 million yuan allocated for this purpose[181]. Governance and Compliance - The board of directors has confirmed the accuracy and completeness of the annual report, ensuring no misleading statements or omissions[4]. - The company maintains complete independence from its controlling shareholders in terms of assets, personnel, finance, and operations[120]. - The company has a transparent and fair performance evaluation and incentive mechanism for senior management[115]. - The company has established specialized committees within the board, including a remuneration and assessment committee[115]. - The company has maintained compliance with relevant laws and regulations, ensuring the protection of shareholders' rights[144]. Environmental Responsibility - The company invested a total of ¥2,783,554.98 in environmental governance and protection during the reporting period[168]. - The company has established a third-party cooperation for the detection of wastewater and air pollutants, ensuring compliance with environmental regulations[168]. - The company adopted energy management practices to reduce carbon emissions, including the use of RO wastewater for cleaning purposes[169]. - The company has committed to a "high efficiency, low energy consumption" green production model to support national carbon reduction goals[169]. - The company has no reported administrative penalties related to environmental issues during the reporting period[170]. Employee Management - The total number of employees at the end of the reporting period was 962, including 863 at the parent company and 99 at major subsidiaries[148]. - The company has implemented a competitive and fair salary system, linking salary packages to business performance and development results[150]. - The company has introduced a diversified incentive mechanism to enhance employee motivation and align efforts with business objectives[150]. - The training program covers all levels and positions, enhancing employee skills through both online and offline training methods[151]. - The company has established lean management projects to improve operational efficiency and employee skills[151]. Future Outlook - The company provided a positive outlook for 2023, projecting a revenue growth of 10% to 12% based on market expansion strategies[181]. - New product launches are expected to contribute an additional 200 million yuan in revenue in 2023, focusing on innovative lens technologies[182]. - The company plans to expand its market presence in Southeast Asia, targeting a 25% increase in market share within the next two years[181]. - Future guidance includes a target of 1.8 billion CNY in revenue for 2023, with a focus on maintaining a sustainable growth trajectory[185]. - The company aims to reduce operational costs by 10% through efficiency improvements and process optimization[183].